Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

FoxN1 overexpression in young mice harms immune cell and skin development.

BMP signaling is important for skin color, affecting melanin production, pigment spread, and cell movement.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Pseudofolliculitis barbae is a chronic skin condition affecting mainly African American and Hispanic individuals, caused by shaving tightly curled hair, and managed by prevention and treatment but not curable.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Trichoscopy helps diagnose and manage hair and scalp disorders in children.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Early regulatory T cells are crucial for normal skin pigmentation.

PRP shows promise for skin and hair treatments but needs more research to confirm its effectiveness.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Non-ablative Er:YAG-laser treatment helps improve life quality for menopausal women with hair loss.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Targeting specific T cells may help treat alopecia areata.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Caspases are enzymes important for both cell death and various non-lethal cell functions, affecting head development and hair growth, with different caspases playing specific roles.

The role of γδT-cells in causing alopecia areata remains unclear.

PRP shows promise for improving healing and hair growth in cosmetic surgery but results can vary.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.